6 Stocks That Caught The Eyes This Week

Advanced Accelerator
Advanced Accelerator

Advanced Accelerator Application SA (ADR) (AAAP) is up an impressive 143% year-to-date. In the last 2 trading days alone, the stock has gained nearly 15% on chatter that Novartis may be interested in acquiring Advanced Accelerator.

Advanced Accelerator is an innovative radiopharmaceutical company that develops, produces and commercializes Molecular Nuclear Medicine products. The lead compound in development is Lutathera for the treatment of neuroendocrine tumors.

Lutathera is under FDA review, for the second time, with a decision expected on January 26, 2018. It was turned down by the FDA last December.

AAAP, which touched an all-time high of $67.37 on Thursday (Sep.28), closed the day’s trading at $65.10, up 8.94%.